As a result, cancer cells acquire metastatic properties (Oft et al, 1998; McEarchern et al, 2001), suggesting that FGF10/FGFR2-IIIb-signalling may promote migration of pancreatic cancer cells through induction of TGF-β1 expression. The gene discussed is FGF10; the disease is cancer.